458
Views
25
CrossRef citations to date
0
Altmetric
Reviews

Novel strategies for the diagnosis and treatment of cardiac amyloidosis

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Marco Basset, Mario Nuvolone, Giovanni Palladini & Giampaolo Merlini. (2020) Novel challenges in the management of immunoglobulin light chain amyloidosis: from the bench to the bedside. Expert Review of Hematology 13:9, pages 1003-1015.
Read now
Paolo Milani, Giovanni Palladini & Giampaolo Merlini. (2018) New concepts in the treatment and diagnosis of amyloidosis. Expert Review of Hematology 11:2, pages 117-127.
Read now

Articles from other publishers (23)

Jorge Andrés Lacouture Fierro, Daniel Andrés Ribero Vargas, Juanita Sánchez Cano, Lina Maria Gaviria Jaramillo, Oliver Gerardo Perilla Suarez, Kenny Mauricio Galvez Cárdenas & Sigifredo Ospina Ospina. (2023) Clinical characterization and outcomes of a cohort of colombian patients with AL Amyloidosis. Colombia Medica 54:3, pages e2025667.
Crossref
Monique C. Minnema, Angela Dispenzieri, Giampaolo Merlini, Raymond L. Comenzo, Efstathios Kastritis, Ashutosh D. Wechalekar, Martha Grogan, Ronald Witteles, Frederick L. Ruberg, Mathew S. Maurer, NamPhuong Tran, Xiang Qin, Sandra Y. Vasey, Brendan M. Weiss, Jessica Vermeulen & Arnaud Jaccard. (2022) Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis. JACC: CardioOncology 4:4, pages 474-487.
Crossref
Maria Lourdes Posadas-Martinez, María Adela Aguirre, Erika Brulc, Maria Soledad Saez, Patricia Sorroche, Gerardo Machnicki, Mariana Fernandez & Elsa Mercedes Nucifora. (2022) Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina. PLOS ONE 17:10, pages e0274578.
Crossref
Jorge Andrés Lacouture-Fierro, Leonardo Mejía-Buriticá & Daniel Andrés Ribero-Vargas. (2022) Amiloidosis AL: conceptos actuales. Medicina y Laboratorio 26:2, pages 119-139.
Crossref
Angela Dispenzieri, Efstathios Kastritis, Ashutosh D. Wechalekar, Stefan O. Schönland, Kihyun Kim, Vaishali Sanchorawala, Heather J. Landau, Fiona Kwok, Kenshi Suzuki, Raymond L. Comenzo, Deborah Berg, Guohui Liu, Arun Kumar, Douglas V. Faller & Giampaolo Merlini. (2021) A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis. Leukemia 36:1, pages 225-235.
Crossref
Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau & Mohamad Mohty. (2021) Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal 11:5.
Crossref
Alberto Albanese, Antoniangela Cocco, Paolo Milani, Stefania Lalli & Giovanni Palladini. (2020) Parkinsonism and dysautonomia: Multiple system atrophy?. Parkinsonism & Related Disorders 77, pages 146-149.
Crossref
Joselle Cook, Eli Muchtar & Rahma Warsame. (2020) Updates in the Diagnosis and Management of AL Amyloidosis. Current Hematologic Malignancy Reports 15:3, pages 155-167.
Crossref
Victoria E Thomas, Justin Smith, Merrill D Benson & Noel R Dasgupta. (2019) Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease. Neurodegenerative Disease Management 9:6, pages 289-299.
Crossref
Romana Ryšavá. (2019) AL amyloidosis: advances in diagnostics and treatment. Nephrology Dialysis Transplantation 34:9, pages 1460-1466.
Crossref
Cindy Varga, Stephanie E. Titus, Denis Toskic & Raymond L. Comenzo. (2019) Use of novel therapies in the treatment of light chain amyloidosis. Blood Reviews 37, pages 100581.
Crossref
Chun Xiang Tang, Steffen E. Petersen, Mihir M. Sanghvi, Guang Ming Lu & Long Jiang Zhang. (2019) Cardiovascular magnetic resonance imaging for amyloidosis: The state-of-the-art. Trends in Cardiovascular Medicine 29:2, pages 83-94.
Crossref
Giampaolo Merlini, Angela Dispenzieri, Vaishali Sanchorawala, Stefan O. Schönland, Giovanni Palladini, Philip N. Hawkins & Morie A. Gertz. (2018) Systemic immunoglobulin light chain amyloidosis. Nature Reviews Disease Primers 4:1.
Crossref
Paolo Milani, Giampaolo Merlini & Giovanni Palladini. (2018) Novel Therapies in Light Chain Amyloidosis. Kidney International Reports 3:3, pages 530-541.
Crossref
Monika Adamska, Anna Komosa, Tatiana Mularek, Joanna Rupa-Matysek & Lidia Gil. (2018) Diagnostic approach to light-chain cardiac amyloidosis and its differential diagnosis. Acta Haematologica Polonica 49:1, pages 9-14.
Crossref
Naveen L. Pereira, Martha Grogan & G. William Dec. (2018) Spectrum of Restrictive and Infiltrative Cardiomyopathies. Journal of the American College of Cardiology 71:10, pages 1130-1148.
Crossref
M. Baroni, S. Nava, G. Quattrocchi, A. Milazzo, C. Giannattasio, A. Roghi & P. Pedrotti. (2017) Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor. Netherlands Heart Journal 26:1, pages 34-40.
Crossref
Martha Grogan, Angela Dispenzieri & Morie A Gertz. (2017) Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart 103:14, pages 1065-1072.
Crossref
Paolo Milani, Giampaolo Merlini & Giovanni Palladini. (2017) Kidney Involvement in Light Chain Amyloidosis. Journal of Onco-Nephrology 1:2, pages 110-119.
Crossref
Lei Zhao & Quan Fang. (2016) Recent advances in the noninvasive strategies of cardiac amyloidosis. Heart Failure Reviews 21:6, pages 703-721.
Crossref
G Merlini, I Lousada, Y Ando, A Dispenzieri, M A Gertz, M Grogan, M S Maurer, V Sanchorawala, A Wechalekar, G Palladini & R L Comenzo. (2016) Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia 30:10, pages 1979-1986.
Crossref
Mario Nuvolone & Giampaolo Merlini. (2016) Systemic amyloidosis: novel therapies and role of biomarkers. Nephrology Dialysis Transplantation, pages gfw305.
Crossref
Anne Blaes, Suma Konety & Peter Hurley. (2016) Cardiovascular Complications of Hematopoietic Stem Cell Transplantation. Current Treatment Options in Cardiovascular Medicine 18:4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.